2013 · 22 citations · 3 references
PharmacyPharmacologyPharmacotherapyBiochemical PharmacologyCardiovascular PharmacotherapyLipid BiochemistryCardiovascular DiseaseCholesterol MetabolismDyslipidemia ManagementDyslipidemia PharmacotherapyLipid MetabolismLipid-lowering TherapyCholesterol Lowering PreventionCholesterol-lowering DietsCholesterol-lowering EffectsHmg-coa Reductase InhibitorsHydroxymethylglutaryl-coa Reductase RegulationLow-density Lipoprotein Cholesterol ReductionOptimal Dose SelectionTreatment Targets In Dyslipidemia
High blood cholesterol level is one of the coronary heart disease risk factor causing high mortality in developed country. Bay leaf containing flavonoids can inhibit HM-CoA reductase enzyme. Objective: The aim of this study is to explore bay leaf infusion effect and optimal dose in reducing blood cholesterol level in dyslipidemic rat model. Method: Experimental complete randomized design was done using 25 male Wistar rats weighing 200-300 gram at Pharmacology Laboratory Maranatha Christian University in January-October 2011. After dyslipidemic condition was induced with high fat diet and PTU (propil thiouracil) 0,01 % for 2 weeks, simvastatin, 2 mL bay leafe infusion was given to each of them in 5, 10, and 20 % concentration orally for 2 weeks. Blood total cholesterol level was measured after high fat diet and PTU and after bay leaf infusion/ simvastatin treatment. Data was analyzed with ANOVA, continued with LSD with α= 0,05. Result: Bay leaf infusion in 5, 10, 20% lowered the blood total cholesterol level (p 0,05). Conclusion: It was concluded that bay leaf infusion in 5, 10, 20 % concentration had the same effect in lowering blood total cholesterol level in dyslipidemic rats and the potency was same as simvastatin.
3
Gregory A. Roth, Stephan D. Fihn, Ali H. Mokdad et al. · Bulletin of the World Health Organization · 2011 · 153 citations · Full text